ArticleFrontiers in immunology2026

Engineering allogeneic type 1 regulatory T cells: a scalable, off-the-shelf platform for restoring immune tolerance.

Molly Javier Uyeda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.